Stephenson Megan L, Wing Deborah A
Department of Obstetrics and Gynecology, University of California, 101 The City Drive South, Building 56, Suite 800, Orange, Irvine, CA.
Department of Obstetrics and Gynecology, University of California, 101 The City Drive South, Building 56, Suite 800, Orange, Irvine, CA.
Semin Perinatol. 2015 Oct;39(6):459-62. doi: 10.1053/j.semperi.2015.07.008.
Labor-induction rates have increased considerably in the United States as well as around the world. With up to half of all induced labors requiring cervical ripening, prostaglandins have been utilized to increase induction success and achieve vaginal delivery. Misoprostol, a synthetic prostaglandin E1 analog has the ability to mimic the changes of spontaneous labor and has been used off label for over 30 years as a labor-induction agent. In the following article, cervical ripening and induction of labor with misoprostol will be discussed. The risks and benefits of misoprostol for ripening and induction and routes of administration will be reviewed, as well as future directions and new developments for its use.
在美国以及全球范围内,引产率都有了显著增长。由于高达半数的引产需要促宫颈成熟,前列腺素已被用于提高引产成功率并实现阴道分娩。米索前列醇是一种合成的前列腺素E1类似物,能够模拟自然分娩的变化,作为引产药物被超适应证使用已有30多年。在接下来的文章中,将讨论米索前列醇促宫颈成熟及引产的相关内容。还将回顾米索前列醇在促宫颈成熟和引产方面的风险与益处、给药途径,以及其使用的未来方向和新进展。